BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23317402)

  • 1. Colesevelam: a new and improved bile acid sequestrant?
    Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
    Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
    Perry CM
    Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colesevelam: a review of its use in hypercholesterolemia.
    Robinson DM; Keating GM
    Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of colesevelam in combination lipid-lowering therapy.
    Jones MR; Nwose OM
    Am J Cardiovasc Drugs; 2013 Oct; 13(5):315-23. PubMed ID: 23913404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.
    Florentin M; Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Curr Med Res Opin; 2008 Apr; 24(4):995-1009. PubMed ID: 18291066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH; Donovan JM; Misir S; Jones MR
    Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
    Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
    Dayer-Berenson L; Finckenor M
    Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
    Esan O; Viljoen A; Wierzbicki AS
    Expert Opin Pharmacother; 2022 Aug; 23(12):1363-1370. PubMed ID: 35968655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
    [No Abstract]   [Full Text] [Related]  

  • 12. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colesevelam hydrochloride: a novel bile acid-binding resin.
    Aldridge MA; Ito MK
    Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid sequestrants and diabetes: introduction and overview to the supplement.
    Jialal I
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1(Suppl 1):S1-2. PubMed ID: 20973745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
    Younk LM; Davis SN
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L; Hermes-Desantis ER
    Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
    Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
    J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
    Goldfine AB; Fonseca VA
    Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.